 Cherry Hill, N.J., Nov. 10, 2021 GLOBE NEWSWIRE -- Vyant Bio, Inc. Vyant Bio, Company Nasdaq: VYNT, an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system CNS and oncology-related diseases. Today, Vyant Bio announced that it will be presenting at the Q4 Investor Summit Micro Small Cap Conference Q4 Investor Summit. The event is being held virtually from November 16-17, 2021. 